基于机器学习的幼儿喘早期预测:COCOA出生队列研究
Chang Hoon Han1,2, Seok-Jae Heo3, Haerin Jang4
1Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea.
概括
预测学前喘是一个挑战. 这项研究开发了一种机器学习模型和基于问卷的工具,在3岁时实现了早期喘预测的高性能. 这两种方法都确定了及时干预的关键风险因素.
科学领域:
- 儿科过敏和免疫学
- 计算生物学和生物信息学
- 流行病学 流行病学
背景情况:
- 在学龄前儿童中早期预测喘对于有效干预至关重要,但仍然是一个重大的临床挑战.
- 这项研究解决了改善诊断工具的需求,以识别三岁前患喘风险的儿童.
研究的目的:
- 开发和验证基于机器学习 (ML) 的3岁喘预测模型.
- 为早期喘预测创建和评估基于问卷的评分工具,将其有效性与ML模型进行比较.
主要方法:
- 利用了来自儿童喘和过敏疾病的起源 (COCOA) 队列的数据. 韩国潜在的出生队列.
- 开发了随机森林机器学习模型,使用高达2年的数据,使用LASSO回归来选择特征.
- 构建并评估了基于问卷的评分工具,与多个ML算法对比,以预测性能.
主要成果:
- 机器学习模型显示,随着数据的积累,预测准确性越来越高,在2年内达到0.774的AUROC.
- 基于问卷的评分工具显示了与ML模型相似的性能,AUROC为0.790.
- 发现的关键预测因素包括父亲的总IgE,母亲的铁补充剂,父母的喘病史,坚果过敏和最近的下呼吸道感染.
结论:
- 成功开发了针对幼儿喘的强大和高性能预测模型.
- 基于问卷的工具由于其易于应用,具有显著的临床实用性.
- 建议在多种人群中进一步验证和对已识别的预测途径进行研究,以提高临床适用性.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:29Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:24Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
01:24Antiasthma Drugs: Methylxanthines
1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K